These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2014-002264-33 Rifaximin in alcoholic hepatitis: effects on inflammatory and metabolic markers. Rifaximin ved alkoholisk hepatitis: Virkning på inflammatoriske og metaboliske markører 2018-05-11 due-trials